Andis Klegeris

7.9k total citations
144 papers, 6.4k citations indexed

About

Andis Klegeris is a scholar working on Neurology, Physiology and Immunology. According to data from OpenAlex, Andis Klegeris has authored 144 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Neurology, 52 papers in Physiology and 36 papers in Immunology. Recurrent topics in Andis Klegeris's work include Neuroinflammation and Neurodegeneration Mechanisms (82 papers), Alzheimer's disease research and treatments (47 papers) and Immune Response and Inflammation (19 papers). Andis Klegeris is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (82 papers), Alzheimer's disease research and treatments (47 papers) and Immune Response and Inflammation (19 papers). Andis Klegeris collaborates with scholars based in Canada, United States and Japan. Andis Klegeris's co-authors include Patrick L. McGeer, Lindsay Joy Spielman, Edith G. McGeer, Jonathan P. Little, Tyler J. Wenzel, Sadayuki Hashioka, Deanna L. Gibson, Douglas G. Walker, Ekta Bajwa and Patrick L. McGeer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain Research.

In The Last Decade

Andis Klegeris

142 papers receiving 6.3k citations

Peers

Countries citing papers authored by Andis Klegeris

Since Specialization

Citations

This map shows the geographic impact of Andis Klegeris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andis Klegeris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andis Klegeris more than expected).

Fields of papers citing papers by Andis Klegeris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andis Klegeris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andis Klegeris. The network helps show where Andis Klegeris may publish in the future.

Co-authorship network of co-authors of Andis Klegeris

This figure shows the co-authorship network connecting the top 25 collaborators of Andis Klegeris. A scholar is included among the top collaborators of Andis Klegeris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andis Klegeris. Andis Klegeris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protective effects of Auranofin on the 6-hydroxydopamine model of Parkinson's disease in rats 2023 ·World Journal of Biology Pharmacy and Health Sciences ·(unknown), Maria Janice Pereira Lopes, Melina Mottin, Andis Klegeris, Kelly Rose Tavares Neves, Gerly Anne de Castro Brito, Glauce Socorro de Barros Viana	2
2	Regulation of the phagocytic activity of astrocytes by neuroimmune mediators endogenous to the central nervous system 2023 ·PLoS ONE ·(unknown), Svetlana Simtchouk, Julien Gibon, Andis Klegeris	4
3	Cardiolipin released by microglia can act on neighboring glial cells to facilitate the uptake of amyloid-β (1–42) 2022 ·Molecular and Cellular Neuroscience ·Tyler J. Wenzel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Svetlana Simtchouk, Julien Gibon, Jane Alcorn, Darrell D. Mousseau, Wesley F. Zandberg, Andis Klegeris	12
4	Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis 2022 ·Frontiers in Immunology ·Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, Arian Tavasol, (unknown), Ramtin Hajibeygi, Sina Shool, (unknown), Andis Klegeris, (unknown), Mostafa Rezaei–Tavirani, Fatemeh Sayehmiri	46
5	Potential neurotoxic activity of diverse molecules released by microglia 2021 ·Neurochemistry International ·(unknown), (unknown), (unknown), Andis Klegeris	38
6	Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease 2020 ·CNS & Neurological Disorders - Drug Targets ·Tyler J. Wenzel, (unknown), Ekta Bajwa, Andis Klegeris	12
7	Microglial targets for effective therapies of Alzheimer’s disease 2020 ·Andis Klegeris	2
8	Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells 2020 ·Molecular and Cellular Neuroscience ·Tyler J. Wenzel, (unknown), (unknown), Andis Klegeris	239
9	Globular adiponectin induces a pro-inflammatory response in human astrocytic cells 2014 ·Biochemical and Biophysical Research Communications ·Zhongxiao Wan, (unknown), Svetlana Simtchouk, Andis Klegeris, Jonathan P. Little	42
10	Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst 2014 ·Journal of Neuroimmunology ·(unknown), Ekta Bajwa, (unknown), Sadayuki Hashioka, Andis Klegeris	32
11	PROBLEM-BASED LEARNING IN A LARGE CLASSROOM SETTING: METHODOLOGY, STUDENT PERCEPTION AND PROBLEM-SOLVING SKILLS 2011 ·EDULEARN proceedings ·Andis Klegeris, (unknown)	8
12	The synthesis and characterization of a series of cobalt(II) β-ketoaminato complexes and their cytotoxic activity towards human tumor cell lines 2011 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), (unknown), Andis Klegeris, W. Stephen McNeil	17
13	Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents 2010 ·Bioorganic & Medicinal Chemistry ·Amal Youssef, (unknown), Erika B. Villanueva, Ibrahim M. El‐Ashmawy, Andis Klegeris	79
14	Thrombin and Prothrombin Are Expressed by Neurons and Glial Cells and Accumulate in Neurofibrillary Tangles in Alzheimer Disease Brain 2006 ·Journal of Neuropathology & Experimental Neurology ·Tetsuaki Arai, Judith Miklossy, Andis Klegeris, Jian‐Ping Guo, Patrick L. McGeer	160
15	Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor 2003 ·British Journal of Pharmacology ·Andis Klegeris, (unknown), Patrick L. McGeer	211
16	Expression of complement messenger RNAs and proteins by human oligodendroglial cells 2003 ·Glia ·Masato Hosokawa, Andis Klegeris, John A. Maguire, Patrick L. McGeer	69
17	Expression of complement messenger RNAs by human endothelial cells 2000 ·Brain Research ·Andis Klegeris, (unknown), Katerina Dorovini‐Zis, Patrick L. McGeer	18
18	Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs) 1999 ·Neuropharmacology ·Andis Klegeris, D G Walker, Patrick L. McGeer	71
19	Acetylcholinesterase-induced respiratory burst in macrophages: evidence for the involvement of the macrophage mannose-fucose receptor 1996 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Andis Klegeris, (unknown), Susan A. Greenfield	15
20	Autoxidation of dopamine: A comparison of luminescent and spectrophotometric detection in basic solutions 1995 ·Free Radical Biology and Medicine ·Andis Klegeris, (unknown), (unknown)	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact